2C-EF Stats & Data

Extremely limited human data exist for 2C‑EF. Identity verification is crucial: reagent tests can suggest a 2C‑x class but are not confirmatory; recent community tests on real‑world 2C‑EF tablets/powders showed inconsistent single‑reagent colours (e.g., Marquis no reaction; Froehde light green; Mecke light purple/pink; Liebermann olive green), so rely on multi‑reagent screening and, when possible, FTIR/GC‑MS/NMR drug‑checking rather than colour tests alone. A 2024 H‑NMR plus external UHPLC‑MS confirmation post supported that authentic 2C‑EF is circulating, while separate community reports cautioned that some blue 10 mg ‘2C‑EF’ tablets in NL tested as 2C‑T—underscoring the need to test each batch. Onset may be delayed up to ~2 hours; avoid redosing during the come‑up to prevent unexpectedly strong peaks. As with related 2C‑x phenethylamines, transient increases in heart rate and blood pressure, muscle tension/twitches, chills, and vasoconstrictive sensations can occur; those with cardiovascular risk should use extra caution. Combining with MAOIs can dangerously potentiate phenethylamines and raise hypertensive/serotonergic risks; tramadol (serotonergic and seizure risk) and DXM (serotonergic) are also high‑risk combinations. SSRIs/SNRIs frequently blunt serotonergic psychedelic effects; people on these medicines may report muted or atypical responses. Insufflation of 2C‑x is widely reported as extremely painful and is discouraged due to causticity and unpredictable absorption; avoid nasal ROA for 2C‑EF. Store the salt form dry, airtight, protected from light, and cold; avoid moisture and temperature cycling (let sealed containers warm to room temp before opening) to minimize degradation. Use precise measurement (mg scale) and consider volumetric dosing for accuracy; avoid eyeballing. Always plan set and setting, avoid driving/unsafe tasks, and keep a benzodiazepine available for severe agitation—recognizing it will also attenuate the psychedelic.